Contact Information
Name: Anna Whelan, MSc in Biomedical Informatics
e-mail: awhelan@uchicago.edu
References
NIH. February 2018. “Prescription Stimulants.” National Institute on Drug Abuse, https://www.drugabuse.gov/publications/drugfacts/prescription-stimulants
Substance Abuse and Mental Health Services Administration. (2017). “Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health.” (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www. samhsa.gov/data/
Bowen, Rita K.; Chestler, Alisa; Coomes, Donna; Dooling, Julie A; Fuller, Brenda; Grijalva, Christine; Kirby, Annessa; Kuehnast, Tanya; Stewart, Elizabeth. “Policy and Procedure Considerations for Health Information Exchange Organizations” Journal of AHIMA 86, no.8 (August 2015): 36-39.
Compton, Wilson M., Beth Han, Carlos Blanco, Kimberly Johnson, and Christopher M. Jones. 2018. “Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.” American Journal of Psychiatry, April, appi.ajp.2018.1. doi:10.1176/appi.ajp.2018.17091048.
Weyandt, Lisa L., Danielle R. Oster, Marisa E. Marraccini, Bergljot Gyda Gudmundsdottir, Bailey A. Munro, Emma S. Rathkey, and Alison McCallum. 2016. “Prescription Stimulant Medication Misuse: Where Are We and Where Do We Go from Here?” Experimental and Clinical Psychopharmacology24 (5). American Psychological Association Inc.: 400–414. doi:10.1037/pha0000093.
Agency for Healthcare Research and Quality. “Health Information Exchange Policy Issues.” US Department of Health and Human Services, http://healthit.ahrq.gov/key-topics/health-information-exchange-policy-issues
NIDA. 5 Feb, 2018. “Prescription Stimulants.” National Institute on Drug Abuse, https://www.drugabuse.gov/publications/drugfacts/prescription-stimulants
Carman, Ashley. 2 May, 2017. “Can a Bluetooth-enabled pill cap help you remember your medicine?” The Verge, https://www.theverge.com/circuitbreaker/2017/5/2/15507102/smart-pill-cap-pillsy-launch
FDA News Release. November 13, 2017. “FDA approves pill with sensor that digitally tracks if patients have ingested their medication.” U.S. Food and Drug Administration, https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm584933.htm
Dullabh, Prashila, Ubri, Petry, and Hovey, Lauren. December 2014. “The State HIE Program Four Years Later: Key Findings on Grantees’ Experiences from a Six-State Review.” NORC at the University of Chicago.
Slabodkin, Greg. 1 March, 2018. “Senate bill would make e-prescribing for controlled substances mandatory.” HealthData Management, https://www.healthdatamanagement.com/news/senate-bill-seeks-to-mandate-e-prescribing-for-controlled-substances
Miliard, Mike. 28 February, 2018. “Bipartisan Senate bill would require EPCS nationwide to fight opioids.” HealthcareIT News, http://www.healthcareitnews.com/news/bipartisan-senate-bill-would-require-epcs-nationwide-fight-opioids
Sacco, Lisa N., Duff, Johnathan H., Sarat, Amanda K. 24 May, 2018. “Prescription Drug Monitoring Programs.” Congressional Research Service Report.
Ernst, Grassley. 11 April, 2018. “Blumenthal Introduce Bipartisan Bill to Combat Prescription Drug Abuse.” Chuck Grassley, https://www.grassley.senate.gov/news/news-releases/ernst-grassley-blumenthal-introduce-bipartisan-bill-combat-prescription-drug
Sullivan, Thomas. 4 May, 2018. “Senate Passes CHRONIC Care Act.” Policy and Medicine, https://www.policymed.com/2017/09/senate-passes-chronic-care-act.html
Conflicts of Interest
I have been using vyvanse medication to treat ADHD for the past 3 years.